Wordt geladen...
Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1
In comparison to total therapy 1 (TT1), the phase 3 trial total therapy 2 (TT2) evaluated the benefit of up-front administration of thalidomide (THAL); TT2 also introduced post-transplant consolidation chemotherapy. With median follow-up times of 5 and 12 years, respectively, outcome comparisons wer...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3649864/ https://ncbi.nlm.nih.gov/pubmed/18371114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2008.06982.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|